Fineline Cube

Follow:
14483 Articles
Policy / Regulatory

China’s NHC Issues Guidelines to Enhance Clinical Department Capacities for Serious Diseases

CompanyDrug

Nanjing Immunophage Biotech’s IPG11406 Approved for SLE Clinical Trial in China

CompanyDeals

Pyrotech (Beijing) Biotechnology Secures $97.37 Million in Series A Financing

Company

Shanghai Henlius Biotech Announces Executive Leadership Changes

CompanyDrug

Zai Lab and argenx Report Positive Preliminary Results from Vyvgart Hytrulo CIDP Study

CompanyDeals

ObsEva SA Regains Full Rights to Nolasiban After Terminating Yuyuan Biological License Deal

CompanyDrug

Janssen’s Rybrevant Meets Primary Endpoint in Phase III NSCLC Study

CompanyDrug

Antengene Corp., Ltd Receives Hong Kong NDA Approval for Xpovio in Relapsed Multiple Myeloma

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-A1811 and Pyrotinib Combo Study

CompanyDeals

Shanghai Xinhengrui Medical Technology Secures Series A Funding for Heart Failure Device Development

CompanyDeals

Beyond Therapeutics Secures Tens of Millions in Pre-Series A Financing for Ophthalmology and Oncology Pipeline

CompanyDrug

Mabwell Bioscience Receives NMPA Approval to Launch 9MW2921 Clinical Study